{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:49Z","timestamp":1792788289660,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.155006","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:22:14Z","timestamp":1792682534000},"page":"155006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["A yeast surface display platform for oral delivery of a SARS-CoV-2 receptor-binding domain dimer inducing mucosal and systemic immunity"],"prefix":"10.1016","volume":"384","author":[{"given":"Xiaoying","family":"Zhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeliang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0005","first-page":"20","article-title":"COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management","volume":"29","author":"Ochani","year":"2021","journal-title":"Infez. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.155006_bb0010","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1016\/S1473-3099(23)00294-3","article-title":"Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy","volume":"23","author":"Abo","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12992-023-00987-w","article-title":"Vaccine hesitancy and equity: lessons learned from the past and how they affect the COVID-19 countermeasure in Indonesia","volume":"20","author":"Sinuraya","year":"2024","journal-title":"Glob. Health"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.155006_bb0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41565-022-01129-w","article-title":"Characterization of nanoparticles-based vaccines for COVID-19","volume":"17","author":"Guerrini","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.155006_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70056","article-title":"Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications","volume":"6","author":"Zhou","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2017.04.008","article-title":"Current state and challenges in developing oral vaccines","volume":"114","author":"Vela Ramirez","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.155006_bb0035","doi-asserted-by":"crossref","first-page":"eadn7786","DOI":"10.1126\/sciadv.adn7786","article-title":"Vaccine targeting to mucosal lymphoid tissues promotes humoral immunity in the gastrointestinal tract","volume":"10","author":"Kocabiyik","year":"2024","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.155006_bb0040","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","article-title":"Oral delivery of proteins and peptides: challenges, status quo and future perspectives","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0045","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s42003-021-02487-2","article-title":"Gastrobodies are engineered antibody mimetics resilient to pepsin and hydrochloric acid","volume":"4","author":"Wicke","year":"2021","journal-title":"Commun. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.155006_bb0050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/mi.2015.121","article-title":"Antigen sampling by intestinal M cells is the principal pathway initiating mucosal IgA production to commensal enteric bacteria","volume":"9","author":"Rios","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jconrel.2022.04.032","article-title":"Yeast as carrier for drug delivery and vaccine construction","volume":"346","author":"Tan","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108422","article-title":"Yeast surface display technology: mechanisms, applications, and perspectives","volume":"76","author":"Li","year":"2024","journal-title":"Biotechnol. Adv."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.155006_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3491","article-title":"Biotechnological potential of yeast cell wall: an overview","volume":"40","author":"Jofre","year":"2024","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121163","article-title":"Bioinspired yeast-based \u03b2-glucan system for oral drug delivery","volume":"319","author":"Wu","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111378","article-title":"Mannose-functionalized antigen nanoparticles for targeted dendritic cells, accelerated endosomal escape and enhanced MHC-I antigen presentation","volume":"197","author":"Pei","year":"2021","journal-title":"Colloids Surf. B Biointerfaces."},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jconrel.2022.09.038","article-title":"Mannose in vaccine delivery","volume":"351","author":"Nahar","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-2760-9_6","article-title":"Progress in yeast glycosylation engineering","volume":"1321","author":"Hamilton","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.155006_bb0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.copbio.2007.09.001","article-title":"Glycosylation engineering in yeast: the advent of fully humanized yeast","volume":"18","author":"Hamilton","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.155006_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083615","article-title":"Establishment of a novel platform for developing oral vaccines based on the surface display system of yeast spores","volume":"26","author":"Si","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12934-021-01584-5","article-title":"Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice","volume":"20","author":"Gao","year":"2021","journal-title":"Microb. Cell Fact."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.155006_bb0105","doi-asserted-by":"crossref","first-page":"10841","DOI":"10.1021\/acsnano.4c14690","article-title":"Orally antigen-engineered yeast vaccine elicits robust intestinal mucosal immunity","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.155006_bb0110","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity"},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.155006_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213716","article-title":"A vaccine of SARS-CoV-2 S protein RBD induces protective immunity","volume":"23","author":"Qu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.155006_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106256","article-title":"Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variants","volume":"26","author":"Montgomerie","year":"2023","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.155006_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29454","article-title":"A superior heterologous prime-boost vaccination strategy against COVID-19: a bivalent vaccine based on yeast-derived RBD proteins followed by a heterologous vaccine","volume":"96","author":"Liu","year":"2024","journal-title":"J. Med. Virol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.155006_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012487","article-title":"Protective RBD-dimer vaccines against SARS-CoV-2 and its variants produced in glycoengineered Pichia pastoris","volume":"20","author":"Zhao","year":"2024","journal-title":"PLoS Pathog."},{"issue":"30","key":"10.1016\/j.ijbiomac.2026.155006_bb0135","doi-asserted-by":"crossref","first-page":"13258","DOI":"10.1073\/pnas.1006344107","article-title":"High-throughput engineering and analysis of peptide binding to class II MHC","volume":"107","author":"Jiang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.155006_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083615","article-title":"Establishment of a novel platform for developing oral vaccines based on the surface display system of yeast spores","volume":"26","author":"Si","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.935573","article-title":"Display of receptor-binding domain of SARS-CoV-2 spike protein variants on the Saccharomyces cerevisiae cell surface","volume":"13","author":"Xing","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12934-020-01316-1","article-title":"Yeast display platform technology to prepare oral vaccine against lethal H7N9 virus challenge in mice","volume":"19","author":"Lei","year":"2020","journal-title":"Microb. Cell Fact."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.155006_bb0155","article-title":"Detection and quantification of SARS-CoV-2 receptor binding domain neutralization by a sensitive competitive ELISA assay","volume":"9","author":"Shalash","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.155006_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12020393","article-title":"Fast and accurate surrogate virus neutralization test based on antibody-mediated blocking of the interaction of ACE2 and SARS-CoV-2 spike protein RBD","volume":"12","author":"Kolesov","year":"2022","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.155006_bb0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.molmed.2023.01.003","article-title":"Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines","volume":"29","author":"Fraser","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.155006_bb0170","article-title":"COVID-19 vaccines (revisited) and oral-mucosal vector system as a potential vaccine platform","volume":"9","author":"Ashraf","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.155006_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70236","article-title":"Oral Ad5 vector-based SARS-CoV-2 vaccine effectively induces mucosal and systemic immune responses in BALB\/c mice","volume":"97","author":"Mao","year":"2025","journal-title":"J. Med. Virol."},{"issue":"51","key":"10.1016\/j.ijbiomac.2026.155006_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202104362","article-title":"Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2","volume":"33","author":"Gale","year":"2021","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12010037","article-title":"Extraordinary titer and broad anti-SARS-CoV-2 neutralization induced by stabilized RBD nanoparticles from strain BA.5","volume":"12","author":"Wang","year":"2023","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-51737-y","article-title":"Amplifying immune responses via a parenteral prime-intranasal boost strategy using a lipidated chitosan nanoparticle-based multi-epitope COVID-19 vaccine","volume":"16","author":"Yi","year":"2026","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.155006_bb0195","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1111\/bph.70423","article-title":"PLGA-particle-based vaccine induces SARS-CoV-2-specific antibody and T-cell responses","volume":"183","author":"Horvath","year":"2026","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-026-01407-x","article-title":"An innovative nasal nanovaccine against SARS-CoV-2 induces systemic and upper airway immunity controlling viral replication","volume":"11","author":"Pagni","year":"2026","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.155006_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1014436","article-title":"Broad and durable protection against SARS-CoV-2 and SARS-CoV by an intranasal chimpanzee adenovirus vaccine expressing tandem RBDs and nucleocapsid","volume":"22","author":"Liu","year":"2026","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.155006_bb0210","article-title":"Mucosal delivery of recombinant SARS-CoV-2 spike receptor-binding domain antigen containing immune-stimulating peptides induces protective immune responses against viral infection in huACE2 mice","volume":"14","author":"Cho","year":"2026","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.155006_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/femsyr\/foab018","article-title":"Yeasts as a promising delivery platform for DNA and RNA vaccines","volume":"21","author":"Silva","year":"2021","journal-title":"FEMS Yeast Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.engmic.2023.100122","article-title":"Engineering Saccharomyces cerevisiae for efficient production of recombinant proteins","volume":"4","author":"Yang","year":"2024","journal-title":"Eng. Microbiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.155006_bb0225","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.5187\/jast.2024.e72","article-title":"Surface displayed porcine epidemic diarrhea virus membrane epitopes on Lactiplantibacillus plantarum stimulates antibody production in mice","volume":"67","author":"Chae","year":"2025","journal-title":"J. Anim. Sci. Technol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.155006_bb0230","doi-asserted-by":"crossref","DOI":"10.1128\/aem.00279-26","article-title":"Oral administration of Lactiplantibacillus plantarum displaying multiple ASFV antigen proteins on the surface induces systemic immune responses in mice","volume":"92","author":"Fan","year":"2026","journal-title":"Appl. Environ. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/vms3.70780","article-title":"Phage-mediated presentation of a conserved HA2 epitope from influenza a virus elicits significant IgY antibody responses in broiler chickens","volume":"12","author":"Lotfi","year":"2026","journal-title":"Vet. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2026.106449","article-title":"Harnessing T4 phage-based platform for efficient design of ready-to-use multiepitope vaccines","volume":"251","author":"Huang","year":"2026","journal-title":"Antiviral Res."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.155006_bb0245","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1021\/acsnano.5c13363","article-title":"Mosaic inverted hemagglutinin extracellular vesicle vaccines elicit protective systemic and mucosal immunity against heterosubtypic influenza infection","volume":"20","author":"Zhu","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-0716-4055-5_13","article-title":"On-demand vaccine production via dock-and-display of biotinylated antigens on bacterial extracellular vesicles","volume":"2843","author":"Weyant","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110034","article-title":"Saccharomyces cerevisiae cells that display norovirus P induce both systemic and mucosal neutralizing antibodies","volume":"594","author":"He","year":"2024","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-026-01458-0","article-title":"Oral delivery of Trichinella spiralis antigens by yeast-derived \u03b2-glucan particles enhances anti-helminth immunity","volume":"11","author":"Liu","year":"2026","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.155006_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/biom16010116","article-title":"Yeast-based vaccine platforms: applications and key insights from the COVID-19 era","volume":"16","author":"Baindara","year":"2026","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.155006_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/idr17050104","article-title":"Oral immunization with yeast-surface display of SARS-CoV-2 antigens in Pichia pastoris induces humoral responses in BALB\/C mice","volume":"17","author":"de Mac\u00eado","year":"2025","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0275","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.95708.3","article-title":"Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern","volume":"13","author":"Ives","year":"2024","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.155006_bb0280","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.155006_bb0285","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acs.molpharmaceut.4c00943","article-title":"Oral DNA vaccine utilizing the yeast cell wall for Dectin-1 receptor-mediated enhancement of mucosal immunity","volume":"22","author":"Liu","year":"2025","journal-title":"Mol. Pharm."},{"issue":"61","key":"10.1016\/j.ijbiomac.2026.155006_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh3634","article-title":"A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates","volume":"6","author":"Pino","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0295","article-title":"Saccharomyces cerevisiae oral immunization in mice using multi-antigen of the African swine fever virus elicits a robust immune response","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.155006_bb0300","article-title":"Oral immunization with recombinant Saccharomyces cerevisiae expressing viral capsid protein 2 of infectious bursal disease virus induces unique specific antibodies and protective immunity","volume":"11","author":"Li","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101828","article-title":"T cell control of SARS-CoV-2: when, which, and where?","volume":"70","author":"Diniz","year":"2023","journal-title":"Semin. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.155006_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020296","article-title":"An early Th1 response is a key factor for a favorable COVID-19 evolution","volume":"10","author":"Gil-Etayo","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2026.155006_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155302","article-title":"Exploration of the immuno-adjuvant effect and mechanism of Anemoside B4 through network pharmacology and experiment verification","volume":"124","author":"Shen","year":"2024","journal-title":"Phytomedicine"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026049585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026049585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:14:17Z","timestamp":1792786457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026049585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":63,"alternative-id":["S0141813026049585"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.155006","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A yeast surface display platform for oral delivery of a SARS-CoV-2 receptor-binding domain dimer inducing mucosal and systemic immunity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.155006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155006"}}